Gene-expression changes in dermal fibroblast cultures exposed to GHK-Cu collagen, decorin, and matrix-metalloproteinase regulation
STEP 3 | Once approved, your prescription is sent to a pharmacy who will ship the medication to your door
To date, none of these has yielded an approved monthly GLP-1, but research is ongoing
There are avenues for compassionate use in truly dire cases, but a middle-aged athlete wanting to speed up tendon healing is not a case of life-threatening need
Published clinical guidelines from organizations including the American Society of Metabolic and Bariatric Surgery and the Obesity Medicine Association have identified GLP-1 receptor agonists as appropriate pharmacological interventions in patients with a BMI of 30 or above (classified as obesity), or BMI of 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea - the same criteria framework used by the FDA in evaluating GLP-1 medications for their obesity management indications